Biotech · Private company
Cybin IRL Limited
Track this companyFree. Adds Cybin IRL Limited to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- CYB003Phase 3 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- CYB003Phase 3 · Major Depressive Disorder (MDD)ClinicalTrials.gov · fetched Nov 12, 2026
- Psychological SupportPhase 3 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Psychological SupportPhase 3 · Major Depressive Disorder (MDD)ClinicalTrials.gov · fetched Nov 12, 2026
- CYB004Phase 2 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
- PsychotherapyPhase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- PsychotherapyPhase 2 · Generalized Anxiety DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPHASE3 · RECRUITING · started Dec 10, 2025ClinicalTrials.gov NCT06793397 · fetched Nov 12, 2026
- Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)PHASE3 · ENROLLING_BY_INVITATION · started Jul 18, 2025ClinicalTrials.gov NCT06605105 · fetched Nov 12, 2026
- "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"PHASE3 · COMPLETED · started Dec 17, 2024ClinicalTrials.gov NCT06564818 · fetched Nov 12, 2026
- A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)PHASE2 · COMPLETED · started May 10, 2024ClinicalTrials.gov NCT06051721 · fetched Nov 12, 2026
- A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive DisorderPHASE1_PHASE2 · COMPLETED · started Aug 2, 2022ClinicalTrials.gov NCT05385783 · fetched Nov 12, 2026